Completed NA INTERVENTIONAL 2-arm NCT01924364

Effect of Concentrating Endogenous Stromal Cells in the Fat Graft Using TGI Device (AFIRM-TGI)

Structural Fat Grafting for Craniofacial Trauma: Effect of Concentrating Endogenous Stromal Cells in the Fat Graft Using the Tissue Genesis Cell Isolation System™ (CIS) Device

Sponsor: J. Peter Rubin, MD

Conditions Facial Injuries Tissue Injury

Interventions Standard of care fat grafting Tissue Genesis Cell Isolation System™ (TGI CIS)

Updated 7 times since 2017 Last updated: Apr 9, 2018 Started: Jun 30, 2012 Primary completion: Sep 28, 2016 Completion: Sep 28, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01924364, this NA trial focuses on Facial Injuries and Tissue Injury and remains completed. Sponsored by J. Peter Rubin, MD, it has been updated 7 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jul 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed · Phase: PHASE1_PHASE2 → NA

▶ Show 2 earlier versions

Feb 2017 — Jul 2017 [monthly]

Active Not Recruiting PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE1_PHASE2

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

J. Peter Rubin, MD

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States